Wissenschaftliche Arbeiten

Prof. Dr. Semih Akı

354 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Xiong HF, Peng B, Wei LL, et al. Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats JOURNAL OF ENDODONTICS 33 (11): 1304-1308 NOV 200

    Quelle: Profilseite auf anadolusaglik.org

  2. Vural M, Esmaeilzadeh S, Basat H, Akı S, Eskiyurt N. The importance of difference between arm span and standing height in elderly postmenopausal osteoporotic women.

    Quelle: Profilseite auf anadolusaglik.org

  3. Osteoporosis International 17: S205-S205 Suppl. 2, MAY 2006

    Quelle: Profilseite auf anadolusaglik.org

  4. Noffsinger AE. Update on Esophagitis Controversial and Underdiagnosed Causes

    Quelle: Profilseite auf anadolusaglik.org

  5. Conference Information: Conference on Advances in Esophageal Pathology, SEP, 2008 San Diego, CA ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 2009; 133 (7): 1087-1095

    Quelle: Profilseite auf anadolusaglik.org

  6. Rabenda V, Hiligsmann M, Reginster JY.Poor adherence to oral bisphosphonate treatment and its consequences: A Review of the Evidence Expert Opinion on Pharmacotherapy 2009;10 (14): 2303-2315

    Quelle: Profilseite auf anadolusaglik.org

  7. Müslümanoğlu L, Akyuz G, Akı S, et al.Evaluation of autonomic nervous system functions in post-stroke patients. American Journal Of Physical Medicine & Rehabilitation 81 (10): 721-725 Oct 2002

    Quelle: Profilseite auf anadolusaglik.org

  8. Takei K, Araki N, Ohkubo T, et al.Comparison of the Anti-Hypertensive Effects of the L/N-Type Calcium Channel Antagonist Cilnidipine, and the L-Type Calcium Channel Antagonist Amlodipine in Hypertensive Patients with Cerebrovascular Disease Internal Medicine 2009; 48(16): 1357-1361

    Quelle: Profilseite auf anadolusaglik.org

  9. Noffsinger AE. Update on Esophagitis Controversial and Underdiagnosed Causes Conference Information: Conference on Advances in Esophageal Pathology, SEP, 2008 San Diego, CA ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 2009; 133 (7): 1087-1095

    Quelle: Profilseite auf anadolusaglik.org

  10. Rabenda V, Hiligsmann M, Reginster JY. Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence expert opinion on pharmacotherapy 2009;10 (14): 2303-2315

    Quelle: Profilseite auf anadolusaglik.org

  11. Iwamoto J, Miyata A, Sato Y, et al.Factors Affecting Discontinuation of Alendronate Treatment in Postmenopausal Japanese Women With Osteoporosis JOURNAL OF THE CHINESE MEDICAL ASSOCIATION.2009;72 (12):619-624

    Quelle: Profilseite auf anadolusaglik.org

  12. Postmenopozal osteoporozda risedronat tedavisinin kemik mineral yoğunluğuna etkisi biokimyasal belirleyicilerle önceden belirlenebilir mi?.Osteoporoz Dünyasından 2007; 12 (4):74-80

    Quelle: Profilseite auf anadolusaglik.org

  13. Papaioannou A, Kennedy CC, Dolovich L, et al. Patient adherence to osteoporosis medications - Problems, consequences and management strategies DRUGS & AGING 24 (1): 37-55 2007

    Quelle: Profilseite auf anadolusaglik.org

  14. Kamatari M, Koto S, Ozawa N, et al. Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate JOURNAL OF BONE AND MINERAL METABOLISM 25 (5): 302-309 SEP 2007

    Quelle: Profilseite auf anadolusaglik.org

  15. Meltem Vural, Hande Başat, Sina Esmaılzadeh, Demirhan Dıraçoğlu, Semih Akı, Nurten Eskiyurt. Osteoporoz tanı ve tedavi unitesıne başvuran hastaların demografık ozellıklerı. 21.Ulusal Fiziksel Tıp ve Rehabilitasyon Kongresi 24-29 Ekim 2007, Kervansaray Otel Lara-Antalya

    Quelle: Profilseite auf anadolusaglik.org

  16. Hande Başat, Sina Esmaılzadeh, Meltem Vural, Semih Akı, Nurten Eskıyurt. Tip II diabet mellitus lu postmenopozal kadınlarda kemik mineral yoğunluğu, düşme ve kırık riskinin değerlendirilmesi. 21.Ulusal Fiziksel Tıp ve Rehabilitasyon Kongresi 24-29 Ekim 2007, Kervansaray Otel Lara-Antalya.

    Quelle: Profilseite auf anadolusaglik.org

  17. Sina Esmaılzadeh, Meltem Vural, Hande Başat, Semih Akı, Nurten Eskıyurt. Postmenopozal osteoporotik kadınlarda düşme riski ile serumda 25 hidroksivitamin D3 düzeyi arasındaki ilişki. 21.Ulusal Fiziksel Tıp ve Rehabilitasyon Kongresi 24-29 Ekim 2007, Kervansaray Otel Lara-Antalya.

    Quelle: Profilseite auf anadolusaglik.org

  18. Nurten Eskıyurt, Nur Kesiktaş Sakar, Demirhan Dıraçoğlu, Semih Akı. Tip II diabetli postmenopozal kadınlarda bazı osteoporoz tedavi protokollerinin karşılaştırılması. 21.Ulusal Fiziksel Tıp ve Rehabilitasyon Kongresi 24-29 Ekim 2007, Kervansaray Otel Lara-Antalya.

    Quelle: Profilseite auf anadolusaglik.org

  19. Nur Kesiktaş, Demirhan Dıraçoğlu, Semih Akı, Nurten Eskiyurt. Comparison of alendronate, risedronate and intranasal calcitonin for treatment of osteoporosis in postmenopausall women with diabetes type II. 8th EUROPEAN CONGRESS on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis" İstanbul 9-12 Nisan 2008

    Quelle: Profilseite auf anadolusaglik.org

  20. Güzin Dilşen, Resa Aydın, Ayşegül Çakmak, Semih Akı, Derya Soy, Aydan Oral. Prevalence health impact and prevalence associated with vertebral deformities in men. 8th EUROPEAN CONGRESS on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis" İstanbul 9-12.NİSAN,2008

    Quelle: Profilseite auf anadolusaglik.org

  21. Kerem Alptekin, Ekin İlke Özgörgü, Nurten Eskiyurt, Semih Akı. Tiroid ve hormon metabolizmasının düşme ve kırık riski üzerindeki etkileri. 3. Ulusal Osteoporoz Kongresi. 15-19 Ekim 2008 Antalya.

    Quelle: Profilseite auf anadolusaglik.org

  22. Akı S. Osteoporozlu Hastalar. Hasta Okulu, 14 Mart 2007 İstanbul Tıp Fakültesi Kemal Atay Anfisi, İstanbul.

    Quelle: Profilseite auf anadolusaglik.org

  23. Akı S. Osteoporotik kırıklar, kırıktan korunma.21. Yüzyılda Osteoporoz, Türkiye Osteoporoz Derneği 3. Ulusal Sempozyumu, 06-08 Nisan .2007 Ankara.

    Quelle: Profilseite auf anadolusaglik.org

  24. Akı S. Klinik Verilerden Gerçek Hayata. 22.Haziran.2007 İstanbul.

    Quelle: Profilseite auf anadolusaglik.org

  25. Akı S. Osteoporozda klinik çalışmalarda etik konular. 3. Ulusal Osteoporoz Kongresi. 15-19 Ekim 2008 Antalya.

    Quelle: Profilseite auf anadolusaglik.org

  26. Öncel A, Eskiyurt N, Özcan E, Yalıman A, Müslümanoğlu L, Akı S, Karan A, Dıraçoğlu D. Düzenleme Kurulu 21.Ulusal Fiziksel Tıp ve Rehabilitasyon Kongresi 24-29 Ekim 2007, Kervansaray Otel Lara-Antalya

    Quelle: Profilseite auf anadolusaglik.org

  27. Güzin Dilşen, Resa Aydın, Ayşegül Çakmak, Semih Akı, Derya Soy, Aydan Oral. Prevalence health impact and prevalence associated with vertebral deformities in men. 8th EUROPEAN CONGRESS on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis" İstanbul 9-12 Nisan 2008

    Quelle: Profilseite auf anadolusaglik.org

  28. Darendeliler F, Poyrazoğlu S, Baş F, Sancaklı O, Gökçay G, Baş N, Akı S, Eskiyurt N. Adiponectin as an early indicator of insulin resistance in non-obese prepubertal children born large for gestational age HORMONE RESEARCH Volume: 70 Pages: 62-62 Supplement: Suppl. 1, 2008

    Quelle: Profilseite auf anadolusaglik.org

  29. Akı S. Kemik Kalitesi. Ruzman Toplantısı 8-10 Mayıs 2009 Adıyaman.

    Quelle: Profilseite auf anadolusaglik.org

  30. Akı S. Sempozyum sonuç bildirgesi. Yaşlılarda Osteoporoz Sempozyumu.1516 Mayıs 2009 Ankara.

    Quelle: Profilseite auf anadolusaglik.org

  31. Akı S. Kemik kalitesi için önlemler ve tedaviye farklı yaklaşımlar. 4. Genç Yaşam Kongresi. 28-31 Mayıs 2009 Kıbrıs.

    Quelle: Profilseite auf anadolusaglik.org

  32. Akı S.Yaşlı Osteoporozunda Kemik Kalitesi. 4.Ulusal Osteoporoz sempozyumu ‘Yaşlanan Kemik, Kırılgan Kemik’ Antalya,18-21 Mart 2010

    Quelle: Profilseite auf anadolusaglik.org

  33. Akı S. Osteoporozda Güncel Öncelikler. 4.Ulusal Osteoporoz sempozyumu ‘Yaşlanan Kemik, Kırılgan Kemik’ Antalya,18-21 Mart 2010

    Quelle: Profilseite auf anadolusaglik.org

  34. Akı S. Postmenopozal Osteoporozlu Kadınlarda Serum 25 Hidroksi Vitamin D ve Düşme Sıklığı Arasındaki İlişki. 4.Ulusal Osteoporoz sempozyumu ‘Yaşlanan Kemik, Kırılgan Kemik’Antalya, 18-21 Mart 2010

    Quelle: Profilseite auf anadolusaglik.org

  35. Akı S. Postmenopozal Kadınlarda Serum 25 Hidroksi Vitamin D Düzeyi ile Kemik Mineral Yoğunluğunun İlişkisi. 4.Ulusal Osteoporoz sempozyumu ‘Yaşlanan Kemik, Kırılgan Kemik’Antalya, 18-21 Mart 2010

    Quelle: Profilseite auf anadolusaglik.org

  36. Akı S. Osteoporoz Tanı ve Tedavi Ünitesine Başvuran 60 Yaş Üstü Erkek Hastaların Demografik Özellikleri.4.Ulusal Osteoporoz sempozyumu ‘Yaşlanan Kemik, Kırılgan Kemik’ Antalya, 18-21 Mart 2010 Müslümanoğlu L, Akı S, Öztürk Y, Soy D, Filiz M, Karan A, Berker E. Motor, sensory and functional recovery in patients with spinal cord lesions. Spinal Cord 1997; 35 (6): 386-389

    Quelle: Profilseite auf anadolusaglik.org

  37. Mulcahey MJ, Hutchinson D, Kozin S.Assessment of upper limb in tetraplegia: Considerations in evaluation and outcomes research. JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT 44 (1): 91-101 2007

    Quelle: Profilseite auf anadolusaglik.org

  38. Mulcahey MJ, Gaughan J, Betz RR, et al.The International Standards for Neurological Classification of Spinal Cord Injury: reliability of data when applied to children and youths, SPINAL CORD 45 (6): 452-459 JUN 2007

    Quelle: Profilseite auf anadolusaglik.org

  39. Lugo LH, Salinas F, Garcia HI. Out-patient rehabilitation programme for spinal cord injured patients: Evaluation of the results on motor FIM score. DISABILITY AND REHABILITATION 29 (11-12): 873-881 2007

    Quelle: Profilseite auf anadolusaglik.org

  40. Wirth B, van Hedel HJA, Kometer B, et al. Changes in activity after a complete spinal cord injury as measured by the Spinal Cord Independence Measure II (SCIM II) NEUROREHABILITATION AND NEURAL REPAIR 22 (2):145-153 MAR-APR 2008

    Quelle: Profilseite auf anadolusaglik.org

  41. Spiess M, Schubert M, Kliesch U, et al. Evolution of tibial SSEP after traumatic spinal cord injury: Baseline for clinical trials. CLINICAL NEUROPHYSIOLOGY 119 (5) 1051-1061 MAY 2008 Aksaç B, Akı S, Karan A, et al.Biofeedback and pelvic floor exercises for the rehabilitation of urinary stress incontinence. Gynecologic and Obstetric Investigation 56 (1): 23-27 2003

    Quelle: Profilseite auf anadolusaglik.org

  42. Rett MT, Simoes JA, Herrmann V, et al. Management of stress urinary incontinence with surface electromyography-assisted biofeedback in women of reproductive age

    Quelle: Profilseite auf anadolusaglik.org

  43. PHYSICAL THERAPY 87 (2): 136-142 FEB 2007

    Quelle: Profilseite auf anadolusaglik.org

  44. Choi H, Palmer MH, Park J. Meta-analysis of pelvic floor muscle training - Randomized controlled trials in incontinent women. NURSING RESEARCH 56 (4): 226-234 JUL-AUG 2007

    Quelle: Profilseite auf anadolusaglik.org

  45. Voorham-van der Zalm PJ, Lycklama a Nijeholt GAB, Elzevier HW, et al. "Diagnostic investigation of the pelvic floor": A helpful tool in the approach in patients with complaints of micturition, defecation, and/or sexual dysfunction. JOURNAL OF SEXUAL MEDICINE 5 (4) : 864-871, APR 2008

    Quelle: Profilseite auf anadolusaglik.org

  46. Santiagu SK, Arianayagam M, Wang A.Urinary incontinence. Pathophysiology and management outline AUSTRALIAN FAMILY PHYSICIAN 37 (3):106-110 MAR 2008

    Quelle: Profilseite auf anadolusaglik.org

  47. Shamliyan TA, Kane RL, Wyman J, et al. Systematic review: Randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. ANNALS OF INTERNAL MEDICINE 148 (6): 459-473 MAR 18 2008

    Quelle: Profilseite auf anadolusaglik.org

  48. Brostrom S, Lose G. Pelvic floor muscle training in the prevention and treatment of urinary incontinence in women - what is the evidence? ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 87 (4):384-402, 2008

    Quelle: Profilseite auf anadolusaglik.org

  49. Demirturk F, Akbayrak T, Karakaya IC, et al. Interferential current versus biofeedback results in urinary stress incontinence. SWISS MEDICAL WEEKLY 138 (21-22): 317-321 MAY 31 2008 Akı S, Eskiyurt N, Akarırmak U, Tüzün F, Eryavuz M, Alper S, Arpacıoğlu O, Atalay F, Kavuncu V, Kokino S, Kuru O, Nas K, Özerbil O, Savaş G, Sendur OF, Soy D, Akyüz G Turkish Osteoporosis Soc. Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis Yonsei Medical Journal 44 (6): 961-967 DEC 30 2003

    Quelle: Profilseite auf anadolusaglik.org

  50. Xiong HF, Peng B, Wei LL, et al.Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats JOURNAL OF ENDODONTICS 33 (11): 1304-1308 NOV 2007

    Quelle: Profilseite auf anadolusaglik.org